These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 4132074

  • 1. Treatment of metastatic carcinoma of the prostate to bone with parathormone and radioactive phosphorous.
    Merrin C, Bakshi S.
    J Surg Oncol; 1974; 6(1):67-72. PubMed ID: 4132074
    [No Abstract] [Full Text] [Related]

  • 2. Radiophosphorous (P32) treatment in carcinoma of the breast and prostate: report of 39 cases.
    Miller AD.
    J Am Osteopath Assoc; 1974 Nov; 74(3):217-22. PubMed ID: 4139177
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Editorial: Treatment of bone metastases from carcinoma of prostate with parathyroid hormone and radioactive phosphorus.
    Rubenfeld S.
    Urology; 1973 Mar; 1(3):268-9. PubMed ID: 4802068
    [No Abstract] [Full Text] [Related]

  • 5. Evaluation of radioactive phosphorus in the palliation of metastatic bone lesions from carcinoma of the breast and prostate.
    Cheung A, Driedger AA.
    Radiology; 1980 Jan; 134(1):209-12. PubMed ID: 6153129
    [Abstract] [Full Text] [Related]

  • 6. Parathormone-potentiated radiophosphorus therapy in prostatic carcinoma.
    Pinck BD, Alexander S.
    Urology; 1973 Mar; 1(3):201-4. PubMed ID: 4802054
    [No Abstract] [Full Text] [Related]

  • 7. The treatment of prostatic bone metastases with parathormone and radioactive phosphorus.
    Tong EC, Finkelstein P.
    J Urol; 1973 Jan; 109(1):71-5. PubMed ID: 4684553
    [No Abstract] [Full Text] [Related]

  • 8. The use of radioactive phosphorus to treat bone pain in metastatic carcinoma of the prostate.
    Morales A, Burr RC, Bruce AW.
    Can Med Assoc J; 1970 Aug 15; 103(4):372-3. PubMed ID: 5447717
    [No Abstract] [Full Text] [Related]

  • 9. [Combination of P32 and testosterone in the treatment of pain due to osseous metastasis of prostate neoplasms].
    García de la Peña E, Sánchez Martín JA, Linazasoro JM, Cifuentes Delatte L.
    Rev Clin Esp; 1974 Sep 30; 134(6):527-34. PubMed ID: 4141512
    [No Abstract] [Full Text] [Related]

  • 10. A comparison of the chemistry of blood from bone and peripheral veins.
    Woodard HQ, Marcove RC.
    Clin Orthop Relat Res; 1969 Sep 30; 66():254-64. PubMed ID: 5388673
    [No Abstract] [Full Text] [Related]

  • 11. Carcinoma of the prostate: the treatment of bone metastases by radioactive phosphorus (32P).
    Ariel IM, Hassouna H.
    Int Surg; 1985 Sep 30; 70(1):63-6. PubMed ID: 4019087
    [Abstract] [Full Text] [Related]

  • 12. Cyproterone acetate in the treatment of advanced carcinoma of the prostate.
    Smith RB, Walsh PC, Goodwin WE.
    J Urol; 1973 Jul 30; 110(1):106-8. PubMed ID: 4713345
    [No Abstract] [Full Text] [Related]

  • 13. PROGNOSTICATION OF CARCINOMA OF THE PROSTATE METASTATIC TO THE SKELETON BY RADIOLOGICAL STUDIES.
    SCHIRMER HK, RICHARDS GJ.
    J Urol; 1964 Dec 30; 92():714-20. PubMed ID: 14241206
    [No Abstract] [Full Text] [Related]

  • 14. Adrenal suppression in the treatment of carcinoma of the prostate.
    Robinson MR, Shearer RJ, Fergusson JD.
    Br J Urol; 1974 Oct 30; 46(5):555-9. PubMed ID: 4422260
    [No Abstract] [Full Text] [Related]

  • 15. The treatment of bone metastases with parathormone followed by radiophosphorus.
    Tong EC, Rubenfeld S.
    Am J Roentgenol Radium Ther Nucl Med; 1967 Feb 30; 99(2):422-34. PubMed ID: 6020191
    [No Abstract] [Full Text] [Related]

  • 16. The effect of drug therapy on the uptake of radioactive fluorine by osseous metastases.
    Kampffmeyer HG, Dworkin H, Carr EA, Bull FE.
    Clin Pharmacol Ther; 1967 Feb 30; 8(5):647-57. PubMed ID: 6054014
    [No Abstract] [Full Text] [Related]

  • 17. Carcinoma of the prostate: the treatment of bone metastases by radiophosphorus.
    Glaser MG, Howard N, Waterfall N.
    Clin Radiol; 1981 Nov 30; 32(6):695-7. PubMed ID: 7307444
    [Abstract] [Full Text] [Related]

  • 18. Effect of calcitonin and hexestrol on urinary excretion of hydroxyproline in a patient with prostatic cancer and bone metastases.
    Matsushita Y, Hasegawa K, Sugimura R, Otomo S, Morii H.
    Endocrinol Jpn; 1974 Apr 30; 21(2):109-13. PubMed ID: 4408206
    [No Abstract] [Full Text] [Related]

  • 19. [Clinico-biochemical parallels in diverse forms of primary hyperparathyroidism].
    Fekson EG, Tishenina RS, Podobedova LI.
    Klin Med (Mosk); 1989 Sep 30; 67(9):92-6. PubMed ID: 2586052
    [Abstract] [Full Text] [Related]

  • 20. The treatment of advanced prostatic carcinoma with medroxyprogesterone.
    Rafla S, Johnson R.
    Curr Ther Res Clin Exp; 1974 Apr 30; 16(4):261-7. PubMed ID: 4208339
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.